Charles Schwab Investment Management Inc Biote Corp. Transaction History
Charles Schwab Investment Management Inc
- $601 Billion
- Q3 2025
A detailed history of Charles Schwab Investment Management Inc transactions in Biote Corp. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 72,826 shares of BTMD stock, worth $183,521. This represents 0.0% of its overall portfolio holdings.
Number of Shares
72,826
Previous 83,339
12.61%
Holding current value
$183,521
Previous $335,000
34.93%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding BTMD
# of Institutions
88Shares Held
15.4MCall Options Held
0Put Options Held
0-
325 Capital LLC New York, NY4.55MShares$11.5 Million4.62% of portfolio
-
Bandera Partners LLC New York, NY2.28MShares$5.76 Million3.0% of portfolio
-
Black Rock Inc. New York, NY1.61MShares$4.04 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.43MShares$3.6 Million0.0% of portfolio
-
Acadian Asset Management LLC Boston, MA695KShares$1.75 Million0.0% of portfolio
About biote Corp.
- Ticker BTMD
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Care Facilities
- Shares Outstandng 7,574,270
- Market Cap $19.1M
- Description
- biote Corp. operates in medical practice-building business within the hormone optimization space. The company offers a platform for Biote-certified practitioners to optimize imbalances in their patient's hormone, vitamin, and mineral levels, as well as prescribe bioidentical hormone therapies and recommend dietary supplements. It also sells Biot...